🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
All patients of the core study who are interested of being treated with EC-...
Status
Completed
Location
Multiple Locations
Start Date
2002-03
Trial ID
NCT00239031
Treatments Being Tested
The aim of the study is to assess the short-term benefit of the combination...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT00154232
Treatments Being Tested
Calcineurin inhibitors (CNI), a potent immunosuppressive drug used in kidne...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2005-11
Trial ID
NCT00332839
A recent therapeutic strategy following renal transplantation includes simu...
Status
Completed
Location
University of Miami
Start Date
2012-11
Trial ID
NCT01680861
Treatments Being Tested
The aim of this study is to assess the safety and efficacy of corticosteroi...
Status
Completed
Location
Royal Prince Alfred Hospital
Start Date
2006-03
Trial ID
NCT00371826
This study will evaluate the safety and efficacy of EC-MPS (ERL080) in comp...
Status
Completed
Location
Novartis Investigative site
Start Date
2002-01
Trial ID
NCT00574743
Treatments Being Tested
The aim of this pilot study is to evaluate efficacy and tolerability of EC-...
Status
Completed
Location
Novartis
Start Date
2004-09
Trial ID
NCT00154206
Treatments Being Tested
The aims of the study was to evaluate the safety and efficacy of early intr...
Status
Completed
Location
Novartis Investigative Site
Start Date
2012-12
Trial ID
NCT01625377
Treatments Being Tested
The aim of this study is to evaluate if the addition of EC-MPS to CsA-ME al...
Status
Completed
Location
Multiple Locations
Start Date
2002-05
Trial ID
NCT00239057
Treatments Being Tested
This study will investigate the safety, tolerability and efficacy of EC-MPS...
Status
Completed
Location
Novartis
Start Date
2005-09
Trial ID
NCT00229138
Treatments Being Tested